96 results for "study_type:"exome sequencing" AND repository:ega"

in 33.77 milliseconds.

• Genomics characterization of BRAF-V600E colorectal cancer patients treated with anti-BRAF/EGFR

  Study EGAS00001006247

• A clinically annotated post-mortem approach to study multi-organ somatic mutational clonality in normal tissues

  Study EGAS00001006332

• Study createine_5

  Description createine_5

  Study EGAS50000000125

• Detection of somatic mutations of angioimmunoblastic T-cell lymphoma

  Study EGAS00001007333

• Study 08

  Study 08 desc

  Study EGAS50000000127

• Study-25-07-2023

  Test study

  Study EGAS50000000124

• Submission 157 - study_title 2

  Submission 157 - description 2

  Study EGAS50000000250

• Submission 40 - study_title 2

  Submission 40 - description 2

  Study EGAS50000000056

• Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer

  Study EGAS00001007372

• Submission 5 - study_title 2

  Submission 5 - description 2

  Study EGAS50000000285

• Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma

  Study EGAS00001004288

• Submission 201 - study_title 2

  Submission 201 - description 2

  Study EGAS50000000311

• Submission 201 - study_title 1

  Submission 201 - description 1 updated

  Study EGAS50000000310

• Submission 64 - study_title 1

  Submission 64 - description 1

  Study EGAS50000000084

• Submission 158 - study_title 2

  Submission 158 - description 2

  Study EGAS50000000254

• Submission 17 - study_title 1

  Submission 17 - description 1

  Study EGAS50000000363

• Targeted Sequencing Xenturion

  Study EGAS00001006697

• Submission 71 - study_title 2

  Submission 71 - description 2

  Study EGAS50000000106

• Study Test 05

  Study Test 05 Desc

  Study EGAS50000000219

• Submission 135 - study_title 2

  Submission 135 - description 1

  Study EGAS50000000225

• Multi-region sequencing of PDAC patients

  Study EGAS00001007379

• Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.

  Study EGAS00001005667

• Submission 12 - study_title 2

  Submission 12 - description 2

  Study EGAS50000000077

• Submission 13 - study_title 1

  Submission 13 - description 1

  Study EGAS50000000078

• Submission 22 - study_title 1

  Submission 22 - description 1

  Study EGAS50000000369